Pulmonary embolism risk in ILD with worsening symptoms
Part of Heart & circulation, Lungs & breathing clinical trials.
This study looks for signs of a blood clot in the lungs (pulmonary embolism) in people with interstitial lung disease whose symptoms suddenly get worse. It aims to find which patients are most likely to have a clot so they can get the right treatment faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with interstitial lung disease (ILD) by a specialist and a special CT scan of your lungs.
- You are having new or worsening shortness of breath, low oxygen levels, chest pain, fainting, or your doctor suspects a blood clot in your lungs.
- You are already scheduled to have a CT angiogram (CTPA) as part of your regular care.
- You are not pregnant.
- You do not have active cancer, a known clotting disorder, or recent heart attack, stroke, major surgery, or trauma.
- Your kidneys are working well enough to receive the contrast dye used for the CT scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for adults with interstitial lung disease (a group of lung conditions that cause scarring). It aims to understand the disease better and may help find new ways to treat it.
This study follows people with interstitial lung disease to learn more about how Chinese medicine can help. If you have ILD and are 18 or older, you may be able to join.
This study compares two types of CT scans to see which one is better at identifying idiopathic pulmonary fibrosis (IPF), a specific type of interstitial lung disease. You may be able to join if you have been diagnosed with ILD and are being discussed by a team of specialists.
This study looks at people aged 18 and older who have a connective tissue disease and lung involvement. It aims to better understand how these lung problems progress and may help doctors choose better care.
This study is testing a new way to speed up the diagnosis of interstitial lung disease (a group of lung scarring conditions). If you have symptoms or scan findings that suggest ILD but haven't been fully diagnosed yet, this trial may help you get a faster, clearer answer.
This study aims to improve how doctors diagnose and classify lung conditions that affect both the air sacs and airways, such as COPD and pulmonary fibrosis. By participating, you may help advance medical knowledge and better understand your own condition.
Hear when a new Pulmonary Embolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.